Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
295.52 USD | -1.55% |
|
+0.35% | -16.25% |
06-30 | United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says | MT |
06-30 | UBS Adjusts Price Target on United Therapeutics to $385 From $410, Maintains Buy Rating | MT |
Insiders
Search
06-16 | MT | |
04-21 | MT | |
04-08 | MT | |
04-07 | MT | |
03-25 | MT | |
12-31 | MT | |
12-17 | MT | |
12-10 | MT | |
11-22 | MT | |
24-10-22 | MT | |
24-09-04 | MT | |
24-08-19 | MT | |
24-07-29 | MT | |
24-07-17 | MT | |
24-06-28 | MT | |
24-06-28 | MT | |
24-06-27 | CI | |
24-06-17 | MT | |
24-06-14 | MT | |
24-05-16 | MT | |
24-05-14 | MT | |
24-05-10 | MT | |
24-05-08 | MT | |
24-05-07 | MT | |
24-05-06 | MT |
No results for this search
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition